Company / Total Assets
Senti Biosciences Holdings, Inc. Total Assets History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$51.2M
FY2025
5-year range
$51.2M / $180.8M
FY2022-FY2025
Trend
-47.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 3 consecutive years, from $181M in FY2022 to $51M in FY2025.
Based on SEC 10-K filings.
$51M in FY2025 with a 3-year CAGR of -34.3%.
Declined from $119M to $51M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -34.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Senti Biosciences Holdings, Inc.'s total assets has declined for 3 consecutive years.
- 3-year CAGR of -34.3%, indicating a declining trend.
- In FY2025, total assets decreased 47.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $51.2M | -47.6% |
| FY2024 | $97.8M | -18.1% |
| FY2023 | $119.5M | -33.9% |
| FY2022 | $180.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026